Rosu, Adeline ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
PAULUS, Virginie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
GUISSARD, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
ZIANT, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
SANCHEZ, Carole ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
Ernst, Marie ; Centre Hospitalier Universitaire de Liège - CHU > > Service des informations médico économiques (SIME)
Desmet, Christophe ; Université de Liège - ULiège > Département des sciences fonctionnelles (DSF)
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Schleich, Florence ; Université de Liège - ULiège > Département des Sciences de l'activité physique et de la réadaptation > Physiologie humaine et physiologie de l'effort physique
K. K. Rathinam, J. J. Abraham, and T. M. Vijayakumar, “Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review,” Current Therapeutic Research, Clinical and Experimental 91 (2019): 45–51, https://doi.org/10.1016/j.curtheres.2019.100571.
M. Castro, A. Papi, C. Porsbjerg, et al., “Effect of Dupilumab on Exhaled Nitric Oxide, Mucus Plugs, and Functional Respiratory Imaging in Patients With Type 2 Asthma (VESTIGE): A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial,” Lancet Respiratory Medicine 13, no. 3 (2025): 208–220, https://doi.org/10.1016/S2213-2600(24)00362-X.
P. Haldar, C. E. Brightling, A. Singapuri, et al., “Outcomes After Cessation of Mepolizumab Therapy in Severe Eosinophilic Asthma: A 12-Month Follow-Up Analysis,” Journal of Allergy and Clinical Immunology 133, no. 3 (2014): 921–923, https://doi.org/10.1016/j.jaci.2013.11.026.
G. Scott, S. Asrat, J. Allinne, et al., “IL-4 and IL-13, Not Eosinophils, Drive Type 2 Airway Inflammation, Remodeling and Lung Function Decline,” Cytokine 162 (2023): 156091, https://doi.org/10.1016/j.cyto.2022.156091.
M. Sabbe, F. Schleich, P. Janssens, and R. Louis, “When Sequential Use of Mepolizumab and Dupilumab in a Severe Atopic Eosinophilic Asthmatic Questions the Role of Eosinophils in Mediating the Clinical Expression of the Disease: A Case Report,” Journal of Medical Case Reports 18, no. 1 (2024): 63, https://doi.org/10.1186/s13256-023-04255-8.
P. Berger, A. Menzies-Gow, A. T. Peters, et al., “Long-Term Efficacy of Dupilumab in Asthma With or Without Chronic Rhinosinusitis and Nasal Polyps,” Annals of Allergy, Asthma & Immunology 130, no. 2 (2023): 215–224, https://doi.org/10.1016/j.anai.2022.11.006.
